Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost

The purpose of this study was to evaluate whether the dose to bladder neck (BN) is a predictor of acute and late urinary toxicity after high-dose-rate brachytherapy (HDRB) boost for prostate cancer.

Source: Brachytherapy - August 31, 2020 Category: Cancer & Oncology Authors: Ibtihel Ben Aicha, Lara Hathout, Damien Carignan, Philippe Despr és, Marie-Claude Lavallée, Sylviane Aubin, Luc Beaulieu, Frédéric Lacroix, William Foster, André-Guy Martin, Eric Vigneault Tags: Prostate Source Type: research